Huge underuse of germline testing for cancer patientsJune 22, 2023Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Drugmakers are abandoning cheap generics, and now U.S. cancer patients can’t get medsJune 22, 2023Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
ACS officer provides ASCO highlights: Targeting hidden cancer, AI in oncologyJune 15, 2023Mixed TopicsBreast CancerMelanomaGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung Cancer
Breast cancer experts and other HCPs disagree on treatment strategies for early BCJune 12, 2023Breast Cancer
Widespread carboplatin, cisplatin shortages: NCCN surveyJune 9, 2023Lung CancerBreast CancerGenitourinary CancerMixed TopicsLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, TransplantationHead & Neck/Thyroid Cancers
ER+/HER2– breast cancer: Is first or second line CDK4/6 inhibitor therapy better?June 7, 2023Breast Cancer
